Research Group on Human Biomonitoring - ongoing projects – University of Copenhagen

Research Group on Human Biomonitoring - ongoing projects


The European Human Biomonitoring Initiative (HBM4EU) is a joint effort of 26 countries and the European Commission, co-funded by Horizon 2020.
For more information visit the national website or the HBM4EU website


COnsortium to Perform Human biomonitoring on a European Scale (FP7 2009-2012), half of the expenses for sampling and analysis nationally to be covered by DEMOCOPHES  EU Life+ and further funding from the ministries of Health, Food and environment, each contributing with 1/6th of the expenses.
For more information please visit the COPHES website.


Endocrine disruption by pesticides. Research financed by the Environmental Protection Agency Pesticide Fund. 2009-2012. 


Nano TEST is a research project under the EU Seventh Framework Programme for Health. The objective is to develop alternative testing strategies and hig-throughput toxicity testing protocols using in vitro and in silico methods essential for the risk assessment of nanoparticles used in medical diagnostics.
For further information please visit the Nano TEST website.


Newborns and Genotoxic exposure risks - is an Integrated project conducted within the European Union's 6th Framework Programme, priority area Food Quality and Safety. Its objective is to investigate the role of prenatal and early-life exposure to genotoxic chemicals present in food and the environment in the development of childhood cancer and immune disorders.
NewGeneris conducts research in the development and application of biomarkers of dietary exposure to genotoxic and immunotoxic chemicals and of biomarkers of early effects, using mother-child birth cohorts and biobanks.
For further information, please consult the NewGeneris website.

Placenta Project

The Placenta Project is a Danish research project which aims to examine the possible placental transfer of various toxic substances.
The project has a Danish home page.


ReProTect is a European research collaboration with 35 partners. Its objective is to develop a novel approach in hazard and risk assessment of reproductive toxicity by combination and application of in vitro, tissue and sensor technologies.
For further information, please visit the ReProTect website.